EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis

Jingjing Han, Rui Hong, Cong Cao, Wanhua Feng, Wei Zhuang, Gui Wang, Jingchao Tang, Ya Yang, Chu Zhang, Aihua Zhou, Xuebin Qu iD

Advanced Science · 2025

DOI: 10.1002/advs.202414550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jingjing Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Science, Jiangsu Medical College, Yancheng, Jiangsu, 224005, China. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Autophagy, Chemokine CXCL13, Spinal Cord. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Project of Jiangsu Provincial Health Commission, Yancheng Basic Research Program Project, Yancheng Natural Science Foundation for Basic Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The damage of blood spinal cord barrier (BSCB) is contributing to the disruption of immune microenvironment within central nervous system during the progression of multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE). Nevertheless, the underlying mechanisms responsible for barrier impairment remain inadequately understood. Here, by analyzing the protein profiles in peripheral blood serum, chemokine (C‐X‐C motif) ligand 13 (CXCL13) was identified to be increased with the progression of MS and EAE. The absence of CXCL13 resulted in alleviation of EAE symptoms, as evidenced by a reduced clinical score, decreased barrier damage, as well as diminished demyelination and inflammatory response in the spinal cord. In the BSCB model, CXCL13 was found to impair barrier structure and function in a dose‐ and time‐dependent manner, which was associated with exacerbated autophagy in endothelial cells, while the application of autophagy inhibitors partially mitigated this damage. Mechanistically, CXCL13 enhanced the expression of RNF6, an E3 ubiquitin‐protein ligase, facilitating the conjugation to Sqstm1 for the ubiquitination at the K314 residue. These findings suggest that CXCL13 significantly contributes to the impairment of the BSCB by promoting RNF6/Sqstm1‐ubiquitination‐induced autophagy during the progression of EAE, thereby offering a promising diagnostic and therapeutic target for MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalAutophagyChemokine CXCL13Spinal CordSequestosome-1 ProteinAnimalsUbiquitinationMiceFemaleMice, Inbred C57BLMultiple SclerosisHumansUbiquitin-Protein LigasesDisease Models, Animal

Stichwörter der Autor:innen

CXCL13RNF6autophagyblood spinal cord barriersexperimental allergic encephalomyelitismultiple sclerosis

Substanzen

Chemokine CXCL13Sequestosome-1 ProteinUbiquitin-Protein LigasesCxcl13 protein, mouse

Autor:innen und Institutionen

  • Department of Basic Medical Science, Jiangsu Medical College, Yancheng, Jiangsu, 224005, China.
  • The Fourth People's Hospital of Yancheng, Yancheng, Jiangsu, 224003, China.
  • Department of Cell Biology and Neurobiology, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
  • Emergency Medicine Department of the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China.
  • Group Health Section, The Affiliated Yancheng Maternity & Child Health Hospital of Yangzhou University, Yancheng, Jiangsu, 224000, China.

ORCID-Profile: Xuebin Qu

Förderung

  • Medical Research Project of Jiangsu Provincial Health Commission
  • Yancheng Basic Research Program Project
  • Yancheng Natural Science Foundation for Basic Research Program
  • Science and Technology Innovation Team and Leading Talent Project of Jiangsu Medical College
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Han, J., Hong, R., Cao, C., Feng, W., Zhuang, W., Wang, G., Tang, J., Yang, Y., Zhang, C., Zhou, A., & Qu, X. (2025). CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis. Advanced Science. https://doi.org/10.1002/advs.202414550

Vancouver

Han J, Hong R, Cao C, Feng W, Zhuang W, Wang G, et al. CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis. Advanced Science. 2025. doi:10.1002/advs.202414550

BibTeX
@article{Han2025,
  author = {Han, Jingjing and Hong, Rui and Cao, Cong and Feng, Wanhua and Zhuang, Wei and Wang, Gui and Tang, Jingchao and Yang, Ya and Zhang, Chu and Zhou, Aihua and Qu, Xuebin},
  title = {CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202414550}
}
Kostenlos starten →